Combined host-conditioning with CTLA4-Ig, tacrolimus, anti-lymphocyte serum, and low-dose radiation leads to stable mixed hematopoietic chimerism

Armitage, 1994, Bone marrow transplantation, New Engl J Med, 330, 82, 10.1056/NEJM199403243301206 Ildstad, 1985, Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance, J Exp Med, 162, 231, 10.1084/jem.162.1.231 Ruedi, 1989, Antiviral T-cell competence and restriction specificity of mixed allogeneic (P1 + P2 → P1) irradiation chimeras, Cell Immunol, 121, 185, 10.1016/0008-8749(89)90016-6 Ildstad, 1984, Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts, Nature, 307, 168, 10.1038/307168a0 Poynton, 1988, T-cell depletion in bone marrow transplantation, Bone Marrow Transplantation, 3, 265 Martin, 1992, Determinants of engraftment after allogeneic marrow transplantation, Blood, 79, 1647, 10.1182/blood.V79.7.1647.1647 Gammie, 1998, A partial conditioning strategy for achieving mixed chimerism in the rat, Exp Hematol, 26, 927 Gammie, 1998, Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts, Circulation, 98, II163 Gill, 1987, The major histocompatibility complex of the rat, Transplantation, 43, 773, 10.1097/00007890-198743060-00001 Hoffman, 1989, Induction of stable chimerism and elimination of graft-vs-host disease by depletion of T-lymphocytes from bone marrow using immunomagnetic beads, Surgery, 106, 354 Horn, 1994, Reappraisal of histologic features of the acute cutaneous graft-vs-host reaction based on an allogeneic rodent model, J Invest Dermatol, 103, 206, 10.1111/1523-1747.ep12392774 Billingham, 1961, Free skin grafting in mammals Lapidot, 1992, Enhancement of T-cell-depleted bone marrow allografts in the absence of GVHD is mediated by a CD8+CD4+ and not by CD8−CD4+ thymocytes, Blood, 80, 2406s, 10.1182/blood.V80.9.2406.bloodjournal8092406 Kaufman, 1994, Phenotypic characterization of a novel bone marrow–derived cell that facilitates engraftment of allogeneic bone marrow stem cells, Blood, 84, 2436, 10.1182/blood.V84.8.2436.2436 Schuchert, 2000, Characterization of a newly discovered T-cell receptor β-chain heterodimer expressed on a CD8+ bone marrow subpopulation that promotes allogeneic stem cell engraftment, Nature Medicine, 6, 904, 10.1038/78667 Shizuru, 1996, Transplantation of purified hematopoietic stem cells, Biol of Blood and Marrow Transplant, 2, 3 Markus, 1993, Induction of donor-specific transplantation tolerance to skin and cardiac allografts using mixed chimerism in (A + B → A) in rats, Cell Transplant, 2, 345, 10.1177/096368979300200418 Pham, 1999, Mixed hematopoietic chimerism induces donor-specific tolerance for lung allografts in rodents, Amer J Respir & Crit Care Med, 159, 199, 10.1164/ajrccm.159.1.9712041 Neipp, 1999, T-cell depletion of allogeneic bone marrow using anti-αβTCR monoclonal antibody, Exp Hematol, 27, 860, 10.1016/S0301-472X(99)00015-6 Pham, 2000, Effects of donor bone marrow infusion in clinical lung transplantation, Ann Thorac Surg, 69, 345, 10.1016/S0003-4975(99)01471-X Corry, 1999, Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients, Ann Surg, 230, 372, 10.1097/00000658-199909000-00010 Tomita, 1994, Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow, Blood, 83, 939, 10.1182/blood.V83.4.939.939 Maloney, 1972, Migration of cells from shielded to irradiated marrow, Blood, 39, 804, 10.1182/blood.V39.6.804.804 Micklem, 1975, Compartments and cell flows within the mouse haemopoietic system. I. Restricted interchange between haemopoietic sites, Cell Tissue Kinet, 8, 219 Nakamura, 1988, The ability of murine CTL clones to reject allogeneic marrow graft with specificity for MHC gene products, J Cell Biochem (Suppl, 12c), 111 Murphy, 1987, Acute rejection of murine bone marrow allografts by natural killer cells and T cells, J Exp Med, 166, 1499, 10.1084/jem.166.5.1499 Donohue, 1993, Characterization of cells emerging at the time of graft failure after bone marrow transplantation from an unrelated marrow donor, Blood, 82, 1023, 10.1182/blood.V82.3.1023.1023 Butturini, 1986, Recipient immune-competent T-lymphocytes can survive intensive conditioning for bone marrow transplantation, Blood, 68, 954, 10.1182/blood.V68.4.954.954 Storb, 1999, Stable mixed hematopoietic chimerism in dog leukocyte antigen–identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation, Blood, 94, 1131, 10.1182/blood.V94.3.1131.415k21_1131_1136 Morris, 1994, Modes of action of FK-506, cyclosporine A, and rapamycin, Transplant Proc, 26, 3272 Janeway, 1994, Signals and signs for lymphocyte responses, Cell, 76, 275, 10.1016/0092-8674(94)90335-2 Gimmi, 1993, Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 co-stimulation, Proc Natl Acad Sci U S A, 90, 6586, 10.1073/pnas.90.14.6586 Noel, 1996, CD28 co-stimulation prevents cell death during primary T-cell activation, J Immunol, 157, 636, 10.4049/jimmunol.157.2.636 Linsley, 1993, The role of the CD28 receptor during T-cell responses to antigen, Ann Rev Immunol, 11, 191, 10.1146/annurev.iy.11.040193.001203 June, 1994, The B7 and CD28 receptor families, Immunol Today, 15, 321, 10.1016/0167-5699(94)90080-9 Linsley, 1991, CTLA4 is a second receptor for the B-cell activation antigen B7, J Exp Med, 174, 561, 10.1084/jem.174.3.561 Walunas, 1996, CTLA4 ligation blocks CD28-dependent T-cell activation, J Exp Med, 183, 2541, 10.1084/jem.183.6.2541 Li, 1998, Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment, Transplantation, 66, 1387, 10.1097/00007890-199811270-00021 Larsen, 1996, Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways, Nature, 381, 434, 10.1038/381434a0 Li, 1999, Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance, Nat Med, 5, 1298, 10.1038/15256 Sykes, 1996, Chimerism and central tolerance, Curr Opin Immunol, 8, 694, 10.1016/S0952-7915(96)80088-4 Wekerle, 1999, Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance, Transplantation, 15;68, 1348, 10.1097/00007890-199911150-00022 Hess, 1997, The immunobiology of syngeneic/autologous graft-vs-host disease Cooper, 1991, The induction of pseudo-graft-vs-host disease following a syngeneic bone marrow transplantation using FK-506, Transplant Proc, 23, 3234 Wekerle, 1998, Extrathymic T-cell deletion and allogeneic stem cell engraftment induced with co-stimulatory blockade is followed by central T-cell tolerance, J Exp Med, 187, 2037, 10.1084/jem.187.12.2037 Wekerle, 2000, Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment, Nat Med, 6, 464, 10.1038/74731 Ildstad, 1985, Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance, J Exp Med, 162, 231, 10.1084/jem.162.1.231 Colson, 1995, Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts, Transplantation, 60, 971, 10.1097/00007890-199511150-00016